EU's breast implant requirements out imminently
This article was originally published in Clinica
The European Commission's Directorate General Enterprise (DGE), which is responsible for medical device regulations, will soon announce that its new requirements for breast implants are ready for publication. These are included in a Commission Decision, a document that is legally enforceable, and will be accompanied by an explanatory memorandum.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.